Trial
NCT03646344
Heme Arginate in Transplantation Study
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Edinburgh
Collaborators
Kidney Cancer UK
Condition
Renal Transplant Rejection
Intervention
Heme Arginate 25 MG/ML
Why stopped
COVID
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-17